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Abstract 
Modifications of signaling pathways and synapses owing to changing behaviors, 
environments, numerous neural modulation as well as brain-tissue injuries is defined as 
neuroplasticity in developmental neurology. The central purpose of the review is to gain a 
better understanding of the relation between stress, depression and neuroplasticity and 
explore potential therapeutic interventions for enhancing neural resilience. We have also 
reviewed the role of different factors like age, stress and sex on inducing neuroplasticity 
within various brain regions.  
 
1. Introduction 
Modifications of signaling pathways and 
synapses owing to changing behaviors, 
environments, various neural processes as 
well as brain-tissue injuries is defined as 
neuroplasticity in developmental neurology 
(Pascual-Leone et al., 2011).  
Neuroplasticity aids the brain in processing 
sensory inputs as well as creating suitable 
adaptive responses to consequent stimuli. 
Nobel laureate Eric Kandel once said, 
“Neuroplasticity is what endows each of us 
with our individuality”. This review focuses 
mainly on how stress can divert the 
protective influence of neuroplasticity to 
instead become harmful. A profound 
understanding of this will help to promote a 
mechanism of ‘resilience’ present in the 
diseased brain using anti-depressant drugs 
as a novel approach to treat stress-related 
brain disorders as well as related mood 
disorders, specifically depression and 
anxiety. The central purpose of the review is 
to gain a better understanding of the relation 
between stress, depression and 
neuroplasticity and explore potential 
therapeutic interventions for enhancing 
neural resilience.  
Brain circuitry can be remodeled by 
experience (Bennett et al.,1964), and 
stressful experiences have functionally 
relevant effects on dendritic arbor, spine, 
and synapse number in many brain regions, 
including the hippocampus, amygdala, and 
the prefrontal cortex (PFC), with effects not 
only on cognitive function but also on 
emotional regulation and other self-
regulatory behaviors (McEwen and 
Gianaros, 2011). Stress can have a profound 
effect on the PFC in particular. The PFC is 
important for working memory i.e. the 
ability to keep events in mind and perform 
self-regulatory and goal-directed behaviors. 
Structural and functional plasticity in this 
brain region illustrates the profound 
capacity of behavioral experiences to 
change neural circuitry and alter brain 
function, with the most significant impact 
occurring during early childhood and 
adolescence. 
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2. Role of stress in neuroplasticity 
Many factors are known to impact 
neuroplasticity and cellular resilience. These 
include alterations in the Hypothalamic-
Pituitary-Adrenal (HPA) axis and glutamate 
neurotransmission as well as impaired 
neurotrophic/neuroprotective signaling. 
Further, stress also affects neuronal 
morphology. For instance, repeated restraint 
stress can lead to atrophy and death of CA3 
pyramidal neurons in the hippocampus in 
both rodents and non-human primates 
(Sapolsky 1996; McEwen 1999). The site 
specificity of these gross morphological 
changes due to stress is noteworthy. Some 
significant instances of these gross 
morphological changes include dendritic 
shortening in the medial prefrontal cortex 
(Cerqueira, 2007; Cook & Wellman, 2004; 
Liston et al., 2006; Radley, Sisti & McEwen 
, 2004), but dendritic growth of neurons in 
basolateral amygdala ((Vyas, Mitra, Rao & 
Chattarji, 2002)), as well as in orbitofrontal 
cortex (Liston et al., 2006) after subjecting 
experimental models to chronic 
immobilization stress. 
Atrophy is equivalent to a decrease in the 
number and length of branch points of the 
apical dendrites of CA3 neurons. Dentate 
granule cells in the hippocampus appear 
comparatively resistant to atrophy and 
death. Neurogenesis is the mitosis and 
generation of progenitor cells in regions of 
the adult mammalian brain such as the 
dentate gyrus of the hippocampus which 
ultimately differentiate into functionally 
integrated neurons throughout life. 
However, stress has shown to reduce the 
neurogenesis of these cells in adult animals 
(Gould & Cameron, 1997, 1998). It is 
believed that neurogenesis provides an 
‘enriched’ environment that greatly 
contributes to cognitive processes like 
memory and learning (Kempermann, Kuhn 
& Gage, 1997; Van Praag, Kempermann & 
Gage, 1999). Brain-derived neurotrophic 
factor (BDNF), a trophic involved in 
survival of striatal neurons in the brain, 
regulation of stress response and in the 
biology of mood disorders, is induced in 
response to neuronal activity, and has been 
shown to play a critical role in cellular 
models of learning and memory (i.e., long-
term potentiation or LTP).Decreased BDNF 
expression in the CA1 and CA3 pyramidal 
and dentate granule cell layers of 
hippocampus after acute or repeated 
immobilization stress has been shown by 
researchers (Smith, Makino, Kvetnanský & 
Post, 1995). 
3. Role of age and gender in 
neuroplasticity 
Age is also an important factor in 
neuroplasticity. Studies have reported 
behavior induced neuronal shrinkage and 
resilience, predominantly in the distal apical 
dendrites of young adults. Importantly, this 
capacity was lost in adult or middle aged rats 
(Bloss, Janssen, McEwen & Morrison, 
2010). It is now known that effects of 
chronic stress carry over to older ages; in 
adult rats, 21 days of chronic restraint stress 
impaired working memory and caused spine 
loss and debranching of dendrites on the 
medial PFC neurons (Hains et al., 2009). It 
is known that in addition to aging, there are 
also sex differences in responses of 
neuroplasticity to stress. Specifically, in 
males, pyramidal neurons in the layer III are 
affected along with apical dendritic length 
shrinkage. This shrinkage is most prominent 
in the distal apical dendritic branches 
amongst the thin spines and it is often 
accompanied by spine loss of approximately 
30% of axospinous synapses (Bloss et al., 
2010, 2011; Cook and Wellman, 2004; 
Radley et al., 2004). Taken together, 
evidence showing that the mature brain has 
greater capacity for plasticity than 
previously believed is carving a path for 
future behavioral and pharmacological-
based therapies that harness neural plasticity 
for recovery.  
While there can be dramatic morphologic 
changes, they may not be permanent. In the 
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absence of stress, neurons, especially in 
young animals, recover structurally and 
functionally almost completely within 3 
weeks (Bloss et al., 2011; Radley et al., 
2005). Although spine density is only 
partially recovered, the dendritic arbor 
recovers fully and this has important 
implications for therapeutic interventions 
because spine loss impairs cognitive 
processes, especially working memory 
performances (Hains et al., 2009). 
Various parts of the brain interconnect with 
each other, either directly or indirectly. The 
prefrontal cortex, amygdala and 
hippocampus interconnect and influence 
each other via direct as well as indirect 
neural activity. Again, this is another 
important aspect which can be harnessed 
while devising therapeutic interventions. Of 
special interest are findings that amygdal 
inactivation blocks stress induced 
hippocampal long term potentiation and 
spatial memory (Kim et al., 2005) while 
stimulation of basolateral amygdala 
enhances dentate gyrus field potentials 
(Ikegaya et al., 1996). Another study also 
reported decreased responsiveness of central 
amygdal output neurons upon stimulation of 
the medial prefrontal cortex (Quirk et al., 
2003). Thus, the amygdala and 
hippocampus act in conjunction. Inhibition 
or stimulation of either one has a directly 
proportional effect on the other and hence 
this connection forms the basis of important 
therapeutic targets.  
4. Potential therapeutic targets 
McEwen and colleagues examined the 
effects of antidepressant treatment on the 
atrophy of CA3 pyramidal neurons and 
demonstrated that an atypical drug- 
Tianeptine (Stablon) which is a Selective 
serotonin reuptake enhancer (in contrast to 
most antidepressant agents) and not a typical 
5-HT selective reuptake inhibitor (like 
fluoxetine) was more effective in enhancing 
neural resilience (Watanabe et al 1992). 
Antidepressant treatment is believed to act 
in a number of ways to counteract the effects 
of chronic stress. These include 
upregulation of the neurogenesis of dentate 
gyrus granule neurons and BDNF, 
especially in the hippocampus and by 
blocking downregulation of BDNF in 
response to stress. BDNF is a good potential 
target because studies have shown that 
direct application of BDNF into the 
midbrain of rats is reported to have 
antidepressant effects in behavioral models 
of depression, including the forced swim 
and learned helplessness paradigms (Siuciak 
et al 1996). BDNF is also a potent 
neurotrophic factor for both the NE and 5-
HT neurotransmitter systems. In addition to 
these, modulation of the altered HPA axis or 
glutamergic activity or the signaling 
cascades, possibly via direct circuit 
stimulations using techniques like deep 
brain stimulation, magnetic stimulation or 
vagus nerve stimulation could make 
promising experimental approaches. 
Therapeutic interventions that could change 
neural architecture and improve cognition 
would be beneficial in stress-induced 
dysfunction. Some studies have 
demonstrated the ability of estrogen to 
potentiate stress-induced plasticity 
(Shansky, Rubinow, Brennan & Arnsten, 
2006). Studies of connectivity between the 
prefrontal cortex, amygdala, and 
hippocampus to elucidate that their 
functional relationships may accelerate the 
development of such therapies. 
Understanding the molecular and cellular 
mechanisms of neuroplasticity, including 
but not limited to signal transduction and 
gene expression, structural alterations of 
neuronal spines and processes, and 
neurogenesis will lead to novel drug targets 
that could prove to be effective and rapidly 
acting therapeutic interventions. In addition, 
studies related to the neuroplastic responses 
to various disorders like depression and 
anxiety are of high significance in the fast 
advancing field of neuroscience. Neuronal 
resilience or the ability of neurons to reverse 
the alterations (in terms of the structure as 
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well as function) makes this aspect a very 
promising treatment for a number of mental 
disorders (Hester et al., 2016; Karkare et al., 
2014; Singh, 2015; Singh et al., 2008, 2013, 
2015, 2016).  
5. Conclusion 
In conclusion, it is critical to primarily gain 
a better understanding of the contribution of 
early life experiences like adverse life-
events on plasticity. Since they are believed 
to have effects on neuroplasticity, it would 
be worthwhile to explore if researchers can 
take advantage of neuro-resilience seen in 
young rodent models and develop 
therapeutic interventions to undo the effects 
of stress by enhancing neuro-resilience 
alongside neuroplasticity. The next step 
would be to evaluate if there’s a way to 
retain resilience and plasticity of prefrontal 
neurons as humans age.  The main aim of 
this review was to focus on the effects of 
stress on prefrontal cortical plasticity. 
Pioneering work on reorganization of the 
adult cerebral cortex and the reversal of 
developmentally induced monocular 
deprivation in visual cortex provides further 
impetus to some likely therapeutic 
strategies. Hence, interventions that can 
change brain architecture and help improve 
cognitive function and self-regulatory 
behaviors certainly hold tremendous 
potential. According to Bavelier et al., 
ongoing studies at the cellular and molecular 
level are beginning to reveal mechanisms 
involving perineuronal nets and 
excitatory/inhibitory balance as possible 
intervention strategies (Bavelier et al., 
2010). Additionally, one can also look at 
possibilities of non-pharmacological 
interventions like yoga, acupuncture, 
exercise, meditation as adjuvants to anti-
depressant drug therapies and whether 
pharmacological and non-pharmacological 
treatments together can give more beneficial 
results in terms of increased neurogenesis 
instead of either one of them alone.  
Finally, advancing techniques like 
optogenetics combined with modern 
imaging methods can greatly accelerate our 
understanding of neuroplasticity and 
vulnerability of the various brain regions, 
especially the prefrontal cortex, spanning 
the entire life course of human beings. These 
studies can also add to the knowledge of 
homologous region adaptations. For 
instance, if brain damage affects one side of 
the parietal lobe, then can the other side 
reorganize itself to replicate the various 
forms of information previously stored in 
the affected side? This knowledge will 
eventually be helpful for developing 
therapeutic interventions that promote 
mental and cognitive health by enhancing 
synaptic properties and neural circuit 
characteristics.  
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